La Dott.ssa Delia Colombo consegue la laurea in Medicina e chirurgia, presso l’Università degli studi di Milano
CURRICULUM VITAE DOTT.SSA DELIA COLOMBO
Generalità anagrafiche
– Nata a Como il 24/6/57
– Residente a Caslino d’Erba 22030, Via A. Diaz n. 17 – cell.3357600852
– Coniugata; una figlia.
Curriculum Accademico
– Maturità Scientifica a pieni voti.
– Laurea in Medicina e Chirurgia, presso l’ Università degli Studi di Milano, nell’anno 1984, a pieni voti (110/110).
– Specializzazione in Dermatologia e Venereologia presso l’ Università degli Studi di Milano nell’anno 1988 (65/70).
– Specializzazione in Farmacologia Clinica presso l’ Università degli Studi di Milano nell’anno 1992 (70/70).
– Master in Dermatologia Plastica, presso l’ Università degli Studi di Milano nell’anno 2004 (70/70).
– Riconoscimento della Laurea Italiana e della Specializzazione in Dermatologia in Svizzera nel 2013.
Esperienza Clinica
– Dal 1981 presso la Divisione di Medicina e gli ambulatori di Radiologia dell’Ospedale Fatebenefratelli di Erba (CO).
– Dal 1983 presso la I Clinica Dermatologica dell’Università di Milano.
– Dal 1987 al 1988 presso il Laboratorio di Immunopatologia Cutanea della I Clinica Dermatologica dell’Università di Milano.
– Dal 1992 Dermatologo presso l’Ospedale Luigi Marchesi di Inzago e presso il proprio Studio in Via Livigno 6 a Milano.
Esperienza Farmaceutica
– Da Marzo 1988, presso l’Istituto Ricerche LPB – Gruppo SANDOZ, Project Leader area dermatologia e membro dell’International Pre-Marketing Group Sandoz-Basilea per i prodotti dermatologici.
– Da Ottobre 1992, presso la SANDOZ S.p.A., Project Leader area Allergo-Asma- Derma.
– Da Aprile del 1996, presso la Novartis farma S.p.A., Medical Advisor nell’Area Immunologia, Dermatologia e Infettivologia.
– Da Ottobre del 1997, presso la Novartis farma S.p.A., Medical Advisor nell’Area Asma, HRT, Infiammazione, Osso e Dermatologia.
– Dal Settembre 2000, presso la Novartis farma S.p.A., Responsabile Medical Affair per la Businness Unit Infettivologia, Immunologia e Trapianti.
– Dal 2007, presso la Novartis farma S.p.A. con il ruolo di dirigente, Gender Medicine Expert.
– Dal 2012, presso la Novartis farma S.p.A. con il ruolo di dirigente, Early Products Manager in Novartis Pharma.
– Dal 2013, presso la Novartis farma S.p.A. con il ruolo di dirigente, Value and Access Head in Novartis Pharma.
ESPERIENZA CLINICA PRIVATA
– Dal 1988 attività privata in ambulatori di Dermatologia.
– Dal 1992 attività privata nel proprio Studio Professionale in area Dermatologica.
– Dal 1994 attività privata di Dermatologia e Dermatologia Estetica.
– Dal 1991 al 2000 analisi personale presso una Psicanalista di area Junghiana.
CONOSCENZE LINGUISTICHE
– Inglese parlato e scritto.
Altro
– Diploma di Ottavo anno di Conservatorio in Chitarra Classica.
TESI ACCADEMICHE
1) “Progetti di razionalizzazione del lavoro in Clinica Dermatologica. Applicazioni del Computer alla Ricerca e all’Assistenza”
Tesi di Laurea in Medicina e Chirurgia; Relatore Prof. Ruggero Caputo (1984).
2) “La cute fetale dalla ottava alla ventitreesima settimana di gestazione. Studio immunoistochimico con Anticorpi Monoclonali”
Tesi di Specializzazione in Dermatologia; Relatore Prof. Ruggero Caputo (1988).
3) “Effetto di priming del farmaco antimicotico terbinafina sul burst respiratorio dei polimorfonucleati”
Tesi di Specializzazione in Farmacologia Clinica; Relatore Prof. Antonio Pecile (1992).
Socio delle seguenti società:
– SIDEMAST: Società Italiana di Dermatologia e Venereologia
– EADV:European Academy of Dermatology
– SSFA: Società di Scienze Farmacologiche Applicate
– GISED-Sidemast: Gruppo di Studio di Farmacologia ed Epidemiologia
– AIDA: Associazione Italiana Dermatologi Ambulatoriali.
– ISPLAD: Società Internazionale di Dermatologia Plastica.
– ISPOR: International Society for Pharmacoeconomics and Outcomes Research
Relazioni a Congressi
– Numerose relazioni a Congressi Nazionali ed Internazionali.
– Corsi per medici in Dermatologia ed Estetica.
– Corsi per ASSL per Medicina di Genere.
– Relazioni su invito in Simposi Regionali per Medicina di Genere.
– 74° Congresso Nazionale FIMMG – Metis 2017 SCARICA PDF
– 19° Congresso Internazionale di Medicina Estetica SCARICA PDF 1 PDF2 PDF3
– Certificato di partecipazione 26th EADV Congress, Geneva, Switzerland SCARICA PDF
MEDICINA di GENERE
– Dal 2007 responsabile del disegno studi di Medicina di Genere in qualunque area di sviluppo clinico della Novartis Farma S.p.A.
– Dal 2007 responsabile delle pubblicazioni, delle relazioni a Congressi e dei corsi specifici di Medicina di Genere della Novartis Farma S.p.A.
Principali Pubblicazioni (indicizzate su Pubmed e/o Google Scholar)
- Colombo, D; Bellia, G; Vassellatti, D; Zagni, E; Sgarbi, S; Rizzoli, S: A gender-medicine post hoc analysis (MetaGeM) project to test sex differences in previous observational studies in different diseases: methodology. Open Access Journal of Clinical Trials, 6, 2014.
- Altomare, G; Ayala, F; Bardazzi, F; Bellia, G; Chimenti, S; Colombo, D; Flori, ML; Girolomoni, G; Micali, G; Parodi, A; Peris, K; Vena, GA: Consensus on the use of cyclosporine in dermatological practice. Giornale italiano di dermatologia e venereologia,149,5,607,2014.
- Peruzzi, M; Colombo, D; Chimenti, I; De Falco, E; Abbate, A; Frati, G; Biondi-Zoccai, G: Comparative Risk-Benefit Analysis of Different Classes of Biologic Agents in Patients with Psoriasis: A Case Study on the Pros and Cons of Mixed Treatment Comparison in Synthesizing Complex Evidence Networks, International Journal of Statistics in Medical Research,3,3,231-247,2014.
- Colombo, D; Cassano, N; Bellia, G; Vena, GA: Gender medicine and psoriasis. World Journal of Dermatology,3,3,36-44,2014.
- Peruzzi, M; Colombo, D; De Falco, E; Chimenti, I; Abbate, A; Frati, G; Biondi-Zoccai, G: Biologic Therapy for Psoriatic Arthritis or Moderate to Severe Plaque Psoriasis: Systematic Review with Pairwise and Network Meta-Analysis. International Journal of Statistics in Medical Research,3,2,74-87,2014.
- Colombo, D; Chimenti, S; Grossi, P; Marchesoni, A; Di Nuzzo, S; Griseta, V; Gargiulo, A; Parodi, A; Simoni, L; Bellia, G: Prevalence of Past and Reactivated Viral Infections and Efficacy of Cyclosporine A as Monotherapy or in Combination in Patients with Psoriatic Arthritis—Synergy Study: A Longitudinal Observational Study. BioMed research international,2014,2014.
- Potena, L; Fiocchi, R; Maiello, C; D’Armini, A; Gerosa, G; Rinaldi, M; Maccherini, M; Livi, U; Frigerio, M; Colombo, D; Brusa, R; Parisi, F: Long-Term Therapy with Everolimus: Promising Results at Three Years of the CERTIC Registry. The Journal of Heart and Lung Transplantation,33,4,S146-S146,2014.
- Stocchi, F; Antonini, A; Barone, P; Tinazzi, M; Zappia, M; Onofrj, M; Ruggieri, S; Morgante, L; Bonuccelli, U; Lopiano, L; Pramstaller, P; Albanese, A; Attar, M; Posocco, V; Colombo, D; Abruzzese, G: Early DEtection of wEaring off in Parkinson disease: The DEEP study. Parkinsonism & related disorders,20,2,204-211,2014.
- Spalletta, G; Caltagirone, C; Padovani, A; Sorbi, S; Attar, Ma; Colombo, D; Cravello, L: Cognitive and Affective Changes in Mild to Moderate Alzheimer’s Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study. PloS one,9,2,e89216,2014.
- Colombo, D; Lunardon, L; Bellia, G: Cyclosporine and herbal supplement interactions. Journal of toxicology,2014,2014.
- Simoni, L; Colombo, D; Bellia, G; Vassellatti, D; Zagni, E; Rizzoli, S; Sgarbi, S: A Gender Medicine Post-Hoc Analysis: Background and Methods of the Metagem Project. Value in Health,17,7,A406,2014.
- Colombo, D; Chimenti, S; Giannetti, A; Caputo, A; Franconi, F; Rizzoli, S; Bellia, G: Therapeutic approaches in psoriasis: a post-hoc analysis of the PSYCHAE study from a gender point of view. Clinical Dermatology,2,2,77-83,2014.
- Colombo, D; Bellia, G: Differenze uomo-donna nella psoriasi. Manuale di Medicina Sesso-genere (Ed. Spec.),19,311-320″,2013.
- Cappelli, G; Di Maria, L; Tisone, G; Spagnoletti, G; Piredda, GB; Colombo, D; Brusa, R; Ponticelli, C: Long-Term Therapy with Everolimus in Kidney Transplant Patients: Two-years Results of the Certic Registry. Transplant International,26,89,2013.
- Colombo, D; Bellia, G. Il paziente psoriasico e l’attenzione alle differenze di genere: lo studio GENDER ATTENTION. Giornale italiano di dermatologia e venereologia,148,Suppl 1,Abstr 21,2013.
- Eibenschutz, L; Colombo, D; Catricalà, C; ,Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas. Case reports in dermatological medicine,2013,2013.
- Colombo, MD; Perego, R; Bellia, G: Cyclosporine-Associated Nephrotoxicity. Open Journal of Nephrology,3,03,168,2013.
- Colombo, MD; Cassano, N; Bellia, G; Vena, GA: Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches. The Scientific World Journal,2013,2013.
- Colombo, MD; Perego, R; Bellia, G: Drug Interaction and Potential Side Effects of Cyclosporine. Advances in Medicine and Biology,74,1,1-24,2013.
- Potena, L; D’Armini, A; Fiocchi, R; Frigerio, M; Gerosa, G; Leonardi, G; Livi, U; Maccherini, M; Maiello, C; Rinaldi, M; Colombo, D; Brusa, R; Parisi, F: Promising Outcomes after Long-Term Therapy with Everolimus: Two-Years Results of the CERTIC Registry. The Journal of Heart and Lung Transplantation,32,4,S199-S200,2013.
- Carmellini, M; Federico, S; Messa, P; Gubbiotti, G; Salvadori, M; Colombo, D; Brusa, R; Ponticelli, C: Promising Outcomes after Long-Term Therapy with Everolimus in Kidney Transplant Patients: Two-Years Results of the CERTIC Registry. American Journal of Transplantation,13,313,2013.
- Abbruzzese, G; Antonini, A; Barone, P; Stocchi, F; Tamburini, T; Bernardi, L; Amboni, M; Vacca, L; Posocco, V; Colombo, D: Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson’s disease. Neurological Sciences,33,6,1319-1327,2012.
- Fiocchi, R; Branzi, A; Frigerio, M; Gerosa, G; Leonardi, G; Livi, U; Maccherini, M; Maiello, C; Parisi, F; Rinaldi, M; D’armini, AM; Colombo, D; Brusa, R; Potena, L: Clinical Practice of Everolimus in Heart Transplant Recipients: Preliminary Results of the Italian Everolimus Registry CERTIC. Transplantation,94,10S,299,2012.
- Bernabei, R; Rossini, PM; Di Cioccio, L; Gragnaniello, D; Luda di Cortemiglia, E; Attar, M; Colombo, D: Compliance and Caregiver Satisfaction in Alzheimer’s Disease: Results from the AXEPT Study. Dementia and geriatric cognitive disorders,2,1,418-432,2012.
- Bandiera, F; Casarin, P; Narciso, P; Milazzo, L; Barone, M; Angeli, E; Picciotto, A; Parruti, G; Girani, M; Mazzucchelli, RI; Colombo, D: ICEBERG study-Follow-Up of a cohort of asymptomatic HBsAg carriers: Elastography and HBV replication after 1 year. Hepatology,56,346A,2012.
- Spalletta, G; Caltagirone, C; Padovani, A; Sorbi, S; Attar, M; Colombo, D: Cognitive and affective changes in mild-to-moderate Alzheimer’s disease patients undergoing switch of cholinesterase inhibitors enrolled in the EVOLUTION study: The effect of different inhibitor/formulation,Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association,8,4,S756-S756,2012.
- Colombo, D; Poggi, S: Clinical profile of cyclosporine in dermatology. Drug Development Research,72,7,634-646,2011.
- Mosconi, G; Colombo, D; Graziani, E; Franceschelli, N; Roi, GS; Totti, V; Nanni, Costa A; Stefoni, S: Physical performance in kidney transplanted patients: a study on desert trekking. Journal of biological regulators and homeostatic agents,25,3,417-425,2010.
- Colombo, D; Ammirati, E: Cyclosporine in transplantation-a history of converging timelines. Journal of biological regulators and homeostatic agents,25,4,493-504,2010.
- Ponticelli, C; Colombo, D; Novara, M; Basilisco, G: Gastrointestinal symptoms impair quality of life in Italian renal transplant recipients but are under‐recognized by physicians. Transplant International,23,11,1126-1134,2010.
- Colombo, D; Cassano, N; Altomare, G; Giannetti, A; Vena, GA: Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study. International journal of immunopathology and pharmacology,23,4,1143-1152,2010.
- Colombo, D; Flori, L; Altomare, G; Aste, N; Sgarbi, S: Clinical outcome evaluation following cyclosporine a treatment in moderate to severe psoriasis: a retrospective study. International journal of immunopathology and pharmacology,23,1,363-367,2009.
- Colombo, D; Egan, CG: Bioavailability of Sandimmun® versus Sandimmun Neoral®: a meta-analysis of published studies. International journal of immunopathology and pharmacology,23,4,1177-1183,2009.
- Colombo, D; Caputo, A; Finzi, A; Andreassi, L; Chimenti, S; Vena, GA; Giannetti, A: Evolution of and risk factors for psychological distress in patients with psoriasis: the PSYCHAE study. International journal of immunopathology and pharmacology,23,1,297-306,2009.
- Franchi, C; Frigerio, E; Spadino, S; Garutti, C; Colombo, DM; Altomare, A; Altomare, G: Hepatitis C viral load decreases after ciclosporin treatment for erosive lichen planus. Clinical and experimental dermatology,34,7,e254-e255,2009.
- Finzi, A; Colombo, D; Caputo, A; Andreassi, L; Chimenti, S; Vena, G; Simoni, L; Sgarbi, S; Giannetti, A: Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. Journal of the European Academy of Dermatology and Venereology,21,9,1161-1169,2007.
- Frigerio, E; Colombo, MD; Franchi, C; Altomare, A; Garutti, C; Altomare, GF: Severe psoriasis treated with a new macrolide: everolimus. British journal of dermatology,156,2,372-374,2007.
- Di Pietro, A; Colombo, MD; Giordan, N: Facial wrinkles correction and skin rejuvenation (biostimulation) by auto-cross-linked hyaluronic acid,Journal of Plastic Dermatology,3,5-10,2007.
- Vena, GA; Cassano, N; Colombo, D; Peruzzi, E; Pigatto, P: Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. Journal of the American Academy of Dermatology,55,4,705-709,2006.
- Colombo, MD; Di Pietro, A: Efficacy and tolerability of cyclosporine microemulsion in chronic idiopathic urticaria. An Italian multicentre collaborative study. Journal of Plastic Dermatology,2,3,2006.
- Calzavara-Pinton, P; Leone, G; Venturini, M; Sala, R; Colombo, D; Parola, LA; Lesnoni I; Sitzia, N; Ferraro, C; Picardo, M: A comparative non randomized study of narrow-band (NB)(312±2 nm) UVB phototherapy versus sequential therapy with oral administration of low-dose Cyclosporin A and NB-UVB phototherapy in patients with severe psoriasis vulgaris. European Journal of Dermatology,15,6,470-473,2005.
- Finzi, A; Colombo, MD; Caputo, A; Andreassi, L; Chimenti, S; Vena, G; Simoni, L; Sgarhi, S; Giannetti, A: Impatto psicopatologico e strategie di coping nella psoriasi. Obiettivi e metodologia dello studio Psoriasis: SurveY for the Control of Anxiety and Epression (PSYCHAE). Giornale Italiano di Dermatologia e Venereologia,140,5,583-590,2005.
- Tosti, A; Piraccini, BM; Ghetti, E; Colombo, MD: Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. Journal of the American Academy of Dermatology,47,1,73-76,2002.
- Cassano, N; Colombo, D; Vena, GA:Guidelines for the use of cyclosporin A in psoriasis. State of the art. Giornale Italiano di Dermatologia e Venereologia,136,6,463-463,2001.
- Camera, E; Cannistraci, C; Briganti, S; Colombo, D; Picardo, M: Scavenging effects of terbinafine on free radicals in vitro. Dermatitis,3,5,1999.
- Tosti, A; Piraccini, BM; Stinchi, C; Colombo, MD: Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up. Dermatology,197,2,162-166,1998.
- Schiraldi, GF; Colombo, MD: Potential use of terbinafine in the treatment of aspergillosis. Reviews In Contemporary Pharmacotherapy,8,349-356,1997.
- Contini, C; Marzola, A; Cultura, R; Colombo, D: Potential use of terbinafine in the treatment of Pneumocystis carinii pneumonia. Reviews In Contemporary Pharmacotherapy,8,363-372,1997.
- Schiraldi, GF; Lo Cicero, S; Colombo, MD; Rossato, D; Ferrarese, M; Soresi, E: Refractory pulmonary aspergillosis: compassionate trial with terbinafine. British Journal of Dermatology,134,s46,25-29,1996.
- Contini, C; Colombo, D; Cultrera, R; Prini, E; Sechi, T; Angelici, E; Canipari, R: Employment of terbinafine against Pneumocystis carinii infection in rat models. British Journal of Dermatology,134,s46,30-32,1996.
- Tosti, A; Piraccini, BM; Stinchi, C; Venturo, N; Bardazzi, F; Colombo, MD: Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. Journal of the American Academy of Dermatology,34,4,595-600,1996.
- Tosti, A; Piraccini, BM; Stinchi, C; Venturo, N; Colombo, MD: Relapse rate of onychomycosis after systemic treatment with terbinafine or itraconazole: a 2-year follow-up. Journal of the European Academy of Dermatology and Venereology,7,suppl 2,157,1996.
- Schiraldi, GF; Colombo, MD; Harari, S; Cicero, S Lo; Ziglio, G; Ferrarese, M; Rossato, D; Soresi, E: Terbinafine in the treatment of non‐immunocompromised compassionate cases of bronchopulmonary aspergillosis. Mycoses,39,1‐2,5-12,1996.
- Tosti, A; Piraccini, BM; Stinchi, C; Venturo, N; Colombo, MD: Standard or pulse therapy with terbinafine. Journal of the European Academy of Dermatology and Venereology,5,1001,188,1995.
- Schiraldi, GF; Cicero, S Lo; Ferrarese, M; Colombo, MD; Rossato, D:Terbinafine in pulmonary refractory aspergillosis: compassionate cases. Journal of the European Academy of Dermatology and Venereology,5,1001,189,1995.
- Vago, T; Baldi, G; Colombo, D; Barbareschi, M; Norbiato, G; Dallegri, F; Bevilacqua, M: Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes. Antimicrobial agents and chemotherapy,38,11,2605-2611,1994.
- Belli, LS; Slim, OA; De Carlis, L; Rondinara, GF; Alberti, A; Zoppi, F; Bellati, G; Fesce, E; Airoldi, A; Colombo, D: Neoral in liver transplant patients: pharmacokinetic study and clinical implications. Transplantation Proceedings,26,5,2981-2982,1994.
- Fiocchi, R; Mamprin, F; Gamba, A; Glauber, M; Catania, S; Cattaneo, G; Torre, L; Bertocchi, C; Ruhrmann, R; Colombo, D: Pharmacokinetic profile of cyclosporine in long-term heart transplanted patients treated with a new oral formulation. Transplantation Proceedings,26,5,2994,1994.
- Vago, T; Colombo, MD; Barbareschi, M; Bevilacqua, M: A pharmacological study about Terbinafine priming effect on the respiratory burst of polymorphonuclear leukocytes. Giornale Italiano di Dermatologia e Venereologia,129,1,I,1994.
- Barbareschi, M; Vago, T; Colombo, D; Bevilacqua, M: Terbinafine induces the PMNL priming effect and enhances in vitro PMNL fungicidal activity against Candida albicans blastospores. Mycoses,36,11‐12,405-409,1993.
- Savonitto, S; Cardellino, G; Doveri, G; Pernpruner, S; Bronzini, R; Milloz, N; Colombo, M D; Sardina, M; Nassi, G; Marraccini, P: Effects of acute exposure to altitude (3,460 m) on blood pressure response to dynamic and isometric exercise in men with systemic hypertension. American Journal of Cardiology,70,18,1493-1497,1992.
- Aste, N; Pau, M; Pinna, AL; Colombo, MD; Biggio, P: Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor. Mycoses,34,7‐8,353-357,1991.
- Albanese, G; Giorgetti, P; Santagostino, L; Di Cintio, R; Colombo, MD: Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine. Giornale Italiano di Dermatologia e Venereologia,124,5,23-27,1989.